about
Tumor suppressor INK4: determination of the solution structure of p18INK4C and demonstration of the functional significance of loops in p18INK4C and p16INK4AMolecular and Pharmacologic Properties of the Anticancer Quinolone Derivative Vosaroxin: A New Therapeutic Agent for Acute Myeloid LeukemiaAlterations in RD(INK4/ARF) -mediated en bloc regulation of the INK4-ARF locus in human squamous cell carcinoma of the head and neck.Erlotinib in African Americans with advanced non-small cell lung cancer: a prospective randomized study with genetic and pharmacokinetic analyses.Atomic resolution (0.97 A) structure of the triple mutant (K53,56,121M) of bovine pancreatic phospholipase A2.Atomic resolution structure of the double mutant (K53,56M) of bovine pancreatic phospholipase A2Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review.Common CYP2D6 polymorphisms affecting alternative splicing and transcription: long-range haplotypes with two regulatory variants modulate CYP2D6 activity.A phase I trial of flavopiridol in relapsed multiple myeloma.Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer.Minocycline, a putative neuroprotectant, co-administered with doxorubicin-cyclophosphamide chemotherapy in a xenograft model of triple-negative breast cancer.Evidence that P12, a specific variant of P16(INK4A), plays a suppressive role in human pancreatic carcinogenesis.Genetic alterations of RD(INK4/ARF) enhancer in human cancer cells.A low-barrier hydrogen bond between histidine of secreted phospholipase A2 and a transition state analog inhibitor.Frequent p16INK4A/CDKN2A alterations in chemically induced Syrian golden hamster pancreatic tumors.Solution structure of the human oncogenic protein gankyrin containing seven ankyrin repeats and analysis of its structure--function relationship.Third-trimester maternal toxicity with nevirapine use in pregnancy.Structural analysis of phospholipase A2 from functional perspective. 2. Characterization of a molten globule-like state induced by site-specific mutagenesis.Stability of extemporaneous erlotinib, lapatinib, and imatinib oral suspensions.Deletions of RDINK4/ARF enhancer in gastrinomas and nonfunctioning pancreatic neuroendocrine tumors.Tumor suppressor INK4: quantitative structure-function analyses of p18INK4C as an inhibitor of cyclin-dependent kinase 4Somatic INK4a-ARF locus mutations: a significant mechanism of gene inactivation in squamous cell carcinomas of the head and neckSuggestive evidence for the involvement of the second calcium and surface loop in interfacial binding: monoclinic and trigonal crystal structures of a quadruple mutant of phospholipase A2Third calcium ion found in an inhibitor-bound phospholipase A2XRCC1-mediated DNA repair is associated with progression-free survival of multiple myeloma patients after autologous stem cell transplant
P50
Q27617472-ED563A08-A345-4509-B106-8CA7A6378903Q28072058-218628A6-F147-4E66-8410-83D225CFAA33Q33916962-7E02EAB6-9F8B-4C5C-85AA-BA667A3A0FE6Q34266864-97554F58-468D-40BC-9C4F-B721EC4203A8Q35950805-61DFFD1D-ADEF-4A8D-A461-7A39E3E5FD89Q36294258-6E50ACEF-AAB5-4B4E-94BE-A4771FECB67CQ37161450-A69AC406-7E1F-4B21-85E9-AFAAEA87EFE7Q37380190-B856135C-FBE3-4F6A-8E4B-536FCC7E8AC5Q37624722-D9189C19-24EB-4E06-B02B-E8041D83C4D8Q37880852-852E3882-374E-44E5-9969-7696E72AEC28Q38750471-2FD129CD-0A36-470A-A0CF-A3CBE4BECE2AQ39144923-87B42166-E318-4B05-8EDF-E81547FD87DFQ41410958-1FD87900-06F6-48DE-833B-62E515C1198EQ44473081-0BDDB167-71FD-470C-8FE4-094059C2DBF9Q44646921-072DBC25-4844-4CC6-993B-556BDDB4CF78Q45067243-9D99D25B-87FC-4B2B-AF67-26EAB8906B0BQ46783931-7A5F2650-7378-4735-9D86-6312EFE47AF5Q52534208-C876D673-A4DF-45AF-A53B-AEB162ED59CDQ53031776-F549575E-3FA9-4907-B278-391CBC42CC4FQ55073249-F234688A-B41F-4D8A-807D-DD91FBEA6D28Q73394934-CB32B8AD-5291-4FB1-BC6E-EFD1782768F3Q73631577-5E7EDFB3-ABB2-44AE-9CE1-E9F9D2567D5CQ79767310-8503FB75-978F-4730-B259-47D3070EEA45Q82904515-DB1D6E41-4477-428B-91B9-84B502D99EB6Q90208550-5BB9CDDF-E231-47FF-AB44-444C73F1B57E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ming J Poi
@ast
Ming J Poi
@en
Ming J Poi
@es
Ming J Poi
@nl
Ming J Poi
@sl
type
label
Ming J Poi
@ast
Ming J Poi
@en
Ming J Poi
@es
Ming J Poi
@nl
Ming J Poi
@sl
prefLabel
Ming J Poi
@ast
Ming J Poi
@en
Ming J Poi
@es
Ming J Poi
@nl
Ming J Poi
@sl
P106
P31
P496
0000-0001-6065-8662